Geron’s worldwide license for embryonic stem cell technology is decreed invalid in Europe.
The adult stem cell company Osiris Therapeutics has announced its final set of two-year results from its clinical trial for Prochymal, one of its adult stem cell products, which has met and surpassed all performance expectations.
Researchers at the University of Wisconsin at Madison have shown that ordinary, non-stem-cell, skin cells can be reprogrammed into heart cells.
Researchers at Northwestern University have once again achieved encouraging results in the treatment of multiple sclerosis with adult stem cells.
In a highly biased and inaccurately distorted report, Time Magazine once again features stem cells as a cover story.
With the Hwang Woo-suk fraud scandal of 2005 still fresh in their national memory, the government of South Korea postpones its verdict on stem cell research.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.